It is banned both in-competition and out-of-competition
This glucose-dependent mechanism makes GLP-1-based therapies safer compared to classical hypoglycemic drugs in critically ill septic patients (46)
Yes, your food choices can help support natural GLP-1 release
Based on preclinical and early human data, activating all three pathways is thought to reduce appetite, improve insulin sensitivity, increase energy expenditure, and support fat breakdown effects that have shown substantial weight loss results in early-phase clinical trials, including a phase 2 study published in the New England Journal of Medicine (2023)
After four weeks, the dosage is gradually increased, usually to 0.5 mg, and eventually to the full dose of 2.4 mg, depending on the patient's response and tolerance
attempting to reconstitute or self-administer this unlicensed compound at home is unsafe and not endorsed by any UK regulatory body